Condensed Consolidated Statements of Operations (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Revenue
Product sales	$ 316,000	$ 136,100	$ 537,080	$ 136,100
Cost of product sales	98,148	45,845	168,366	65,193
Gross profit from product sales	217,852	90,255	368,714	70,907
Other Revenue
Retained royalties	2,348	4,384	4,952	17,760
Other income	13,653	9,643	17,473	58,322
Total other revenue	16,001	14,027	22,425	76,082
Expenses
Selling expenses	66,032	35,758	138,026	103,933
Personnel and consulting expenses	424,121	278,732	819,144	619,739
General and administrative expenses	317,305	413,417	511,026	814,176
Interest expense	112,895	43,971	217,680	76,738
Interest expense - accelerated upon conversion of OID notes	35,109		35,109
Loss on conversion of OID notes	43,288		43,288
Loss on settlement of note and warrant			132,301
Unrealized loss (gain) on derivative instruments	25,952	9,439	11,720	(8,728)
Total Expenses	1,024,702	781,317	1,908,294	1,605,858
Loss before income taxes	(790,849)	(677,035)	(1,517,155)	(1,458,869)
Provision (benefit) for income taxes
Net loss	$ (790,849)	$ (677,035)	$ (1,517,155)	$ (1,458,869)
Basic and diluted loss per share	$ (0.03)	$ (0.04)	$ (0.07)	$ (0.09)
Basic and diluted weighted average number of common shares outstanding:	23,082,699	16,146,013	21,567,885	15,868,892